Researchers have shown an inability to detect methylated vimentin using MSP in CRC patient stool samples (n = 8) that contained low concentrations of human DNA. However, these researchers demonstrated that methyl-binding domain protein enrichment prior to MSP increased assay sensitivity [34]. The gene discussed is VIM; the disease is colorectal carcinoma.